BridgeBio Oncology Therapeutics, Inc (BBOT) vs Evommune Inc. (EVMN)
BridgeBio Oncology Therapeutics, Inc and Evommune Inc. are both Biotechnology companies. BridgeBio Oncology Therapeutics, Inc and Evommune Inc. are of similar size ($319.9M and $309.9M). Across the 10 metrics below, Evommune Inc. leads on 6 and BridgeBio Oncology Therapeutics, Inc on 4.
Valuation
Profitability
| Metric | BBOT | EVMN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (252.10%) | (141.99%) | (57.72%) |
| Return on assets | (96.69%) | (62.71%) | (49.22%) |
| Return on invested capital | (127.66%) | (82.46%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack